Step into the future of bioscience applications with our Endotoxin Controlled Excipient (ECE) portfolio, designed to meet the highest standards in biomedical innovation. Featuring VACCIPRO® for vaccine stabilization, trusted by leading vaccine manufacturers worldwide, and MEDELLAPRO® for pioneering applications in parenteral medical devices, 3D bioprinting, wound care and more.
Download the eBook now to discover how these pharmaceutical grade solutions can transform your biomedical products - and explore our vision for animal-free gelatin developed at our Biotech Hub in Frankfurt.